Denmark Approves Merck’s COVID-19 Antiviral Treatment in EU First

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co. Inc. and Ridgeback Biotherapeutics LP. Merck & Co. Inc./Handout via Reuters

Denmark on Dec. 16 approved an antiviral COVID-19 drug produced by Merck and Ridgeback Biotherapeutics for at-risk patients with symptoms, including the elderly.

The Scandinavian country became the first in the European Union to approve the antiviral treatment called molnupiravir. The pill is still under review by the European Medicines Agency (EMA).